← Back to Search

Device

Head Cooling for Stroke (COOLHEAD-2 Trial)

N/A
Waitlist Available
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- All patients with anterior circulation acute ischemic stroke planned to undergo endovascular thrombectomy will be screened for recruitment.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from time of application in the emergency department until the end of the endovascular thrombectomy procedure
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if using a cooling device on the head during a specific surgical procedure is safe and possible.

Who is the study for?
This trial is for patients experiencing an acute ischemic stroke who are scheduled to undergo a procedure called endovascular thrombectomy. It's not open to individuals outside of this group.
What is being tested?
The study is testing the safety and how doable it is to use external active conductive head cooling on patients during their clot removal procedure for stroke.
What are the potential side effects?
Since this is a feasibility and safety study, specific side effects aren't listed, but they may include discomfort or skin issues at the cooling site, among others that will be monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from time of application in the emergency department until the end of the endovascular thrombectomy procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and from time of application in the emergency department until the end of the endovascular thrombectomy procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to the intervention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment armExperimental Treatment1 Intervention
Head cooling

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
810 Previous Clinical Trials
886,254 Total Patients Enrolled
35 Trials studying Stroke
40,517 Patients Enrolled for Stroke
~27 spots leftby Dec 2025